Protalix BioTherapeutics
PLX
#8349
Rank
โ‚น20.88 B
Marketcap
โ‚น259.74
Share price
6.11%
Change (1 day)
16.42%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.81. In 2024 the company made an earnings per share (EPS) of โ‚น3.63 a decrease over its 2023 EPS that were of โ‚น10.88.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-51.88%
2024โ‚น3.63-66.67%
2023โ‚น10.88-138.71%
2022-โ‚น28.10-50%
2021-โ‚น56.21181.82%
2020-โ‚น19.95-82.11%
2019-โ‚น111.51-31.67%
2018-โ‚น163.19-72.31%
2017-โ‚น589.30124.14%
2016-โ‚น262.92-147.54%
2015โ‚น553.03-290.62%
2014-โ‚น290.126.67%
2013-โ‚น271.98130.77%
2012-โ‚น117.86-69.77%
2011-โ‚น389.8419.44%
2010-โ‚น326.38-12.2%
2009-โ‚น371.7136.67%
2008-โ‚น271.98-37.5%
2007-โ‚น435.1750%
2006-โ‚น290.123.23%
2005-โ‚น281.05138.46%
2004-โ‚น117.86-74%
2003-โ‚น453.31-0%
2002-โ‚น453.31-50%
2001-โ‚น906.61233.33%
2000-โ‚น271.98-84.21%
1999-โ‚น1,723-24%
1998-โ‚น2,267-600%
1997โ‚น453.31-16.67%
1996โ‚น543.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น123.30 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น390.75 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น9.97-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น112.42 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel